American Capital Advisory’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
WT
American Capital Advisory's EW Position: Q2 2026 in Review
American Capital Advisory increased its Edwards Lifesciences (EW) stake by 5% in Q2 2026, buying an estimated $1.09K and bringing the position to 275 shares worth $24.9K. The position accounts for 0.01% of the portfolio, ranked #287.
American Capital Advisory first reported a position in EW in Q4 2023 and has held it in 10 quarters since. 774 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- American Capital Advisory held 275 shares of Edwards Lifesciences worth $24.9K as of Q2 2026.
- American Capital Advisory bought 13 Edwards Lifesciences shares in Q2 2026, an estimated $1.09K.
- Edwards Lifesciences made up 0.01% of American Capital Advisory's portfolio in Q2 2026, its #287 holding.
- American Capital Advisory first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 10 quarters since.
- 774 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on American Capital Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.